MX2016004487A - Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados. - Google Patents

Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.

Info

Publication number
MX2016004487A
MX2016004487A MX2016004487A MX2016004487A MX2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A MX 2016004487 A MX2016004487 A MX 2016004487A
Authority
MX
Mexico
Prior art keywords
fatty acids
polyunsaturated fatty
soft capsules
enteric soft
pharmaceutical compositions
Prior art date
Application number
MX2016004487A
Other languages
English (en)
Inventor
Zhang Peijin
A Fatmi Aqeel
Original Assignee
Banner Life Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banner Life Sciences Llc filed Critical Banner Life Sciences Llc
Publication of MX2016004487A publication Critical patent/MX2016004487A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen en la presente una composición farmacéutica que contiene ácidos grasos poliinsaturados y métodos para su fabricación. En particular, se describe en el presente composiciones farmacéuticas que consisten en cápsulas blandas entéricas que contienen ácidos grasos polinsaturados omega -3. La composición farmacéutica oral descrita en la presente es útil son útiles como suplementos nutricionales o para el tratamiento de enfermedades cardiovasculares como dislipidemia y niveles altos de triglicéridos.
MX2016004487A 2013-10-30 2014-10-29 Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados. MX2016004487A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361897794P 2013-10-30 2013-10-30
US201462017489P 2014-06-26 2014-06-26
PCT/US2014/062892 WO2015066176A1 (en) 2013-10-30 2014-10-29 Enteric soft capsules comprising polyunsaturated fatty acids

Publications (1)

Publication Number Publication Date
MX2016004487A true MX2016004487A (es) 2016-11-10

Family

ID=52995731

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016004487A MX2016004487A (es) 2013-10-30 2014-10-29 Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.

Country Status (6)

Country Link
US (2) US9895332B2 (es)
EP (2) EP3062785B1 (es)
CA (1) CA2926335C (es)
ES (1) ES2826201T3 (es)
MX (1) MX2016004487A (es)
WO (1) WO2015066176A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6317425B2 (ja) 2013-03-15 2018-04-25 パセオン ソフトジェルズ インコーポレイティド シルク系カプセル剤
US9895332B2 (en) * 2013-10-30 2018-02-20 Patheon Softgels, Inc. Enteric soft capsules comprising polyunsaturated fatty acids
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
CN106135376B (zh) * 2015-03-30 2019-03-22 维斯克凡科技（苏州）有限公司 用于可食性胶原肠衣的端部封闭部以及获得该端部封闭部的方法
US10966937B2 (en) * 2015-05-04 2021-04-06 Cytometix, Inc. Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs
US10631564B2 (en) 2015-06-19 2020-04-28 University Of Southern California Enterically coated microparticle compositions and methods for modified nutrient delivery
US10744070B2 (en) 2015-06-19 2020-08-18 University Of Southern California Enteral fast access tract platform system
US20170304150A1 (en) * 2016-04-19 2017-10-26 Ascent Pharmaceuticals, Inc. Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms
CN109562184B (zh) * 2016-07-06 2023-02-03 快力胶囊股份有限公司 硬度改善的硬胶囊及其制造方法
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
WO2019094702A1 (en) 2017-11-10 2019-05-16 Cocoon Biotech Inc. Ocular applications of silk-based products
CN112996500A (zh) * 2018-06-15 2021-06-18 优美佳生物技术有限公司 用于调节elovl2的组合物和方法
CN109528679B (zh) * 2019-01-15 2023-03-14 南宁富莱欣生物科技有限公司 一种包含多种维生素的软胶囊及其生产方法
EP4674410A3 (en) 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment
JP2023532180A (ja) * 2020-06-02 2023-07-27 アール．ピー．シェーラー テクノロジーズ，エルエルシー 遅延放出ソフトゲルカプセル
IT202100008483A1 (it) * 2021-04-06 2022-10-06 Stefano Sala Kit per il rilascio controllato di sostanze volatili
AR126384A1 (es) * 2021-07-06 2023-10-11 Scherer Technologies Llc R P Cápsula blanda
CN113598376B (zh) * 2021-08-11 2023-11-21 郑州瑞普生物工程有限公司 一种应用于含铜离子片剂产品中的叶酸微囊粉的制备方法
TW202530700A (zh) * 2023-10-02 2025-08-01 加拿大商９１６３ ０３８４魁北克股份有限公司 使用維生素ｅ的乳糜微粒血症之評估
CN120617195B (zh) * 2025-08-15 2025-10-10 广州东智盟化妆品有限公司 一种淀粉基软胶囊皮及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US6482516B1 (en) 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US8685445B2 (en) 2002-10-01 2014-04-01 Banner Pharmacaps Inc. Enteric composition for the manufacture of soft capsule wall
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US7022713B2 (en) 2004-02-19 2006-04-04 Kowa Co., Ltd. Hyperlipemia therapeutic agent
WO2007066232A2 (en) * 2005-10-07 2007-06-14 Ocean Nutrition Canada Ltd. Salts of fatty acids and methods of making and using thereof
US20070148248A1 (en) * 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
US20120171285A1 (en) * 2007-06-01 2012-07-05 Opheim Joar A Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
US20090011012A1 (en) 2007-07-06 2009-01-08 Baum Seth J Fatty acid compositions and methods of use
SI2424356T1 (en) 2009-04-29 2018-01-31 Armarin Pharmaceuticals Ireland Limited A stable pharmaceutical composition and procedures for its use
US20110177061A1 (en) * 2009-07-10 2011-07-21 Martek Biosciences Corporation Methods of treating and preventing neurological disorders using docosahexaenoic acid
CA2706270C (en) 2010-06-03 2020-01-07 Accucaps Industries Limited Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation
US20140017308A1 (en) 2010-09-08 2014-01-16 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
WO2012032415A2 (en) 2010-09-08 2012-03-15 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
AR082930A1 (es) * 2010-09-08 2013-01-16 Pronova Biopharma Norge As Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina
CN104321055A (zh) 2012-01-06 2015-01-28 翁特拉制药公司 游离酸形式的ω-3多不饱和脂肪酸的富含dpa组合物
US9585896B2 (en) 2012-04-04 2017-03-07 Pronova Biopharma Norge As Compositions comprising omega-3 fatty acids and vitamin D for psoriasis, and methods and uses thereof
WO2013155430A1 (en) 2012-04-13 2013-10-17 Banner Pharmacaps, Inc. Soft elastic capsules containing tablets and liquid or semisolid fills and methods for their manufacture
US9895332B2 (en) * 2013-10-30 2018-02-20 Patheon Softgels, Inc. Enteric soft capsules comprising polyunsaturated fatty acids
US9895333B2 (en) * 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids

Also Published As

Publication number Publication date
US10188624B2 (en) 2019-01-29
EP3062785A1 (en) 2016-09-07
EP3062785A4 (en) 2017-07-19
CA2926335C (en) 2021-11-23
US20150118298A1 (en) 2015-04-30
ES2826201T3 (es) 2021-05-17
US9895332B2 (en) 2018-02-20
CA2926335A1 (en) 2015-05-07
EP3062785B1 (en) 2020-07-22
US20180169051A1 (en) 2018-06-21
EP3738586A1 (en) 2020-11-18
WO2015066176A1 (en) 2015-05-07

Similar Documents

Publication Publication Date Title
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
NZ702325A (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
PH12016501194B1 (en) Lipid comprising long chain polyunsaturated fatty acids
IL234104A (en) METHOD FOR PREPARING Medium-length fatty acids with triglycerides
UY34225A (es) Producción de DHA y otros LC-PUFAs (Acidos Grasos Poliinsaturados) en plantas.
PH12014500105A1 (en) Fatty acid compositions
WO2012013331A3 (en) Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
EA201791885A1 (ru) Смесь жирных кислот и её применение для лечения воспалительных патологий
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
PH12014502024A1 (en) Nutritional compositions including rrr-alpha tocopherol and polyunsaturated fatty acids
MA40417A (fr) Mélange d'acides gras et de palmitoyl éthanolamide pour utilisation dans le traitement de pathologies inflammatoires et allergiques
MX2017016320A (es) Composiciones nutricionales y metodos para promover el desarrollo cognitivo.
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
EP3109315A4 (en) Method for the enrichment of microalgae biomass in polyunsaturated fatty acids
NZ734149A (en) Millicapsule formulations comprising polyunsaturated free fatty acids
MY186566A (en) Omega-3 compositions, dosage forms, and methods of use
SG11201801576XA (en) Free polyunsaturated fatty acid-containing composition and manufacturing method therefor
PH12018502207A1 (en) Methods of manufacturing nutritional formulations
EP3040415A4 (en) Omega-3 UNSATURATED FATTY ACID ENZYME AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID
EP3027180A4 (en) Compositions and methods of the treatment of fatty acid metabolism disorders
EP3076961A4 (en) Omega-3 fatty acid articles of manufacture, and methods and apparatus for making same
GB201209344D0 (en) Omega-6 enriched pufa phospholipids
EA201890479A1 (ru) Гидрофобный гель на основе витамина е без продуктов силикона для местного применения
HK1220606A1 (zh) 包含非可氧化脂肪酸的天然脂类